Placenta accreta spectrum ultrasound stage and fetal growth
- PMID: 35964250
- PMCID: PMC10087882
- DOI: 10.1002/ijgo.14399
Placenta accreta spectrum ultrasound stage and fetal growth
Abstract
Objective: to evaluate fetal growth in pregnancies complicated by placenta accreta spectrum (PAS) and to compare fetal growth between cases stratified by ultrasound stage of PAS.
Methods: This was a prospective multicenter cohort study of women diagnosed with PAS between January 2018 and December 2021. We grouped participants into cases by ultrasound stage (PAS stage 1-3) and controls (PAS0). Fetal growth centiles at three timepoints with median gestational ages of 21 ± 1 weeks (interquartile range [IQR], 20 ± 1-22 ± 0 weeks), 28 ± 0 weeks (IQR, 27 ± 0-28 ± 5 weeks), and 33 ± 0 weeks (IQR, 32 ± 1-34 ± 0 weeks) and birth weight centiles were compared between cases and controls and between those with PAS stratified by ultrasound stage.
Results: A total of 53 women met inclusion criteria, with a mean age of 37 years (standard deviation, ±4.0 years) and body mass index of 27 kg/m2 (standard deviation, ±5.8 kg/m2 ). Median (IQR) fetal weight centiles were around the 50th centile at each timepoint, with no difference between groups. The incidence of small for gestational age (birth weight ≤ 10th percentile) and large for gestational age (birth weight ≥ 90th percentile) was 11.3% (n = 6) and 15.1% (n = 8), respectively, with no differences by ultrasound stage. The median birth weight centile was 64 (IQR, 26-85), with no differences between cases and controls or by ultrasound stage.
Conclusions: In our cohort, a diagnosis of PAS was not associated with fetal growth restriction.
Keywords: birth weight; fetal growth; placenta accreta spectrum; ultrasound stage.
© 2022 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.
Conflict of interest statement
The authors have no conflicts of interest.
Figures


Similar articles
-
Evaluation of fetal growth and birth weight in pregnancies with placenta previa with and without placenta accreta spectrum.J Perinat Med. 2024 Oct 22;53(1):9-14. doi: 10.1515/jpm-2024-0290. Print 2025 Jan 29. J Perinat Med. 2024. PMID: 39428759
-
Impact of placenta previa with placenta accreta spectrum disorder on fetal growth.Ultrasound Obstet Gynecol. 2019 Nov;54(5):643-649. doi: 10.1002/uog.20244. Ultrasound Obstet Gynecol. 2019. PMID: 30779235 Free PMC article.
-
Prenatal ultrasound staging system for placenta accreta spectrum disorders.Ultrasound Obstet Gynecol. 2019 Jun;53(6):752-760. doi: 10.1002/uog.20246. Epub 2019 May 6. Ultrasound Obstet Gynecol. 2019. PMID: 30834661
-
Epidemiology of placenta previa accreta: a systematic review and meta-analysis.BMJ Open. 2019 Nov 12;9(11):e031193. doi: 10.1136/bmjopen-2019-031193. BMJ Open. 2019. PMID: 31722942 Free PMC article.
-
Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.Ultrasound Obstet Gynecol. 2021 Jun;57(6):903-909. doi: 10.1002/uog.22183. Ultrasound Obstet Gynecol. 2021. PMID: 32840934
Cited by
-
Evaluation of fetal growth and birth weight in pregnancies with placenta previa with and without placenta accreta spectrum.J Perinat Med. 2024 Oct 22;53(1):9-14. doi: 10.1515/jpm-2024-0290. Print 2025 Jan 29. J Perinat Med. 2024. PMID: 39428759
-
Prenatal detection of placenta accreta spectrum using a sonographic checklist.Acta Obstet Gynecol Scand. 2025 Apr;104 Suppl 1(Suppl 1):56-65. doi: 10.1111/aogs.14943. Epub 2024 Oct 2. Acta Obstet Gynecol Scand. 2025. PMID: 39356049 Free PMC article.
-
Guidelines on Placenta Accreta Spectrum Disorders: A Systematic Review.JAMA Netw Open. 2025 Jul 1;8(7):e2521909. doi: 10.1001/jamanetworkopen.2025.21909. JAMA Netw Open. 2025. PMID: 40679824 Free PMC article.
-
Placenta Previa et Percreta: A Potentially Life-Threatening Condition.Diagnostics (Basel). 2023 Feb 1;13(3):539. doi: 10.3390/diagnostics13030539. Diagnostics (Basel). 2023. PMID: 36766644 Free PMC article.
-
Biology and Pathophysiology of Placenta Accreta Spectrum Disorder.Obstet Gynecol. 2025 Jun 1;145(6):611-620. doi: 10.1097/AOG.0000000000005903. Epub 2025 Apr 10. Obstet Gynecol. 2025. PMID: 40209229 Free PMC article. Review.
References
-
- O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996;175(6):1632‐1638. - PubMed
-
- Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51(12):2627‐2633. - PubMed
-
- Collins SL, Ashcroft A, Braun T, et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound Obstet Gynecol. 2016;47(3):271‐275. - PubMed
-
- Cali G, Forlani F, Lees C, et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol. 2019;53(6):752‐760. - PubMed
-
- Jauniaux E, Ayres‐de‐Campos D, Langhoff‐Roos J, Fox KA, Collins S. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20‐24. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous